How will brexit affect travel for people with long-term health conditions? Lords to investigate

The Committee will consider whether travel insurance will increase and how access to treatment might be affected for those living with diabetes and kidney conditions both in the UK and in the EU after Brexit.

At 10:30am the Committee will hear from:

• Fiona Loud, Policy Director, Kidney Care UK
• Robin Hewings, Head of Policy, Knowledge and Insight, Diabetes UK

Questions the witnesses are likely to be asked include:

• Will people with kidney conditions or diabetes have to pay higher travel insurance premiums should the UK and EU not come to a deal on reciprocal healthcare?
• What reciprocal healthcare priorities would stakeholders hope to see reflected in a potential Withdrawal Agreement, and what sort of transitional arrangements would they wish to see?
• How might non-resident EU-27 citizens who visit the UK access healthcare for long-term conditions post-Brexit?

The evidence session will begin at 10.30am in Committee Room 2 of the House of Lords.